globenewswire.com
BioPorto Receives FDA 510(k) Clearance for NGAL Test in the United States First Test to Aid in...
December 7, 2023 Announcement no. 20 BioPorto Receives FDA 510(k) Clearance for NGAL Test in the United StatesFirst Test to Aid in Assessing AKI Risk for...